Thermo Fisher authorizes $5 billion share repurchase program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Join SI Premium – FREE
Thermo Fisher Scientific Inc. (NYSE: TMO) announced its board of directors authorized the repurchase of $5 billion of common stock shares through open market or negotiated transactions.
The authorization carries no expiration date, according to a company statement. The repurchase program allows the company to buy back shares at its discretion.
Thermo Fisher Scientific reported annual revenue of approximately $40 billion. The company operates in life sciences research, analytical services, laboratory productivity, diagnostics, and pharmaceutical manufacturing sectors.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson Controls names new chief legal and chief information officers
- Lumen and Microsoft expand co-sell deal for enterprise AI networks
- Zeo Energy reports H1 2026 solar revenue, outlines storage strategy
Create E-mail Alert Related Categories
Corporate News, Stock BuybacksRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
